1. Kangfuxin Accelerates Extraction Socket Healing by Promoting Angiogenesis Via Upregulation of CCL2 in Stem Cells.
- Author
-
Gao ZR, Zhou YH, Zhao YQ, Zhao J, Ye Q, Zhang SH, Feng Y, Tan L, Liu Q, Chen Y, Ouyang ZY, Hu J, Dusenge MA, Feng YZ, and Guo Y
- Subjects
- Humans, Animals, Mice, Up-Regulation, Stem Cells metabolism, Wound Healing, Osteogenesis physiology, Cell Differentiation physiology, Periodontal Ligament metabolism, Chemokine CCL2 metabolism
- Abstract
Kangfuxin (KFX) shows potential in wound healing, but its role in socket healing is unclear. This research finds increased bone mass, mineralization, and collagen deposition in KFX-treated mice. Mouse bone marrow mesenchymal stem cells, human periodontal ligament stem cells (hPDLSCs), and human dental pulp stem cells (hDPSCs) are treated with KFX under osteogenic induction. RNA-sequencing reveals upregulated chemokine-related genes, with a threefold increase in chemokine (C-C motif) ligand 2 (Ccl2). The conditioned medium (CM) of hPDLSCs and hDPSCs treated with KFX promotes endothelial cell migration and angiogenesis. Ccl2 knockdown abolishes CM-induced endothelial cell migration and angiogenesis, which can be reversed by recombinant CCL2 treatment. KFX-treated mice showed increased vasculature. In conclusion, KFX increases the expression of CCL2 in stem cells, promoting bone formation and mineralization in the extraction socket by inducing endothelial cell angiogenesis. © 2023 American Society for Bone and Mineral Research (ASBMR)., (© 2023 American Society for Bone and Mineral Research (ASBMR).)
- Published
- 2023
- Full Text
- View/download PDF